Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh

BACKGROUND: The radical cure of Plasmodium vivax requires treatment with an 8-aminoquinoline drug, such as primaquine and tafenoquine, to eradicate liver hypnozoite stages, which can reactivate to cause relapsing infections. Safe treatment regimens require prior screening of patients for glucose-6-p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Malar J
Auteurs principaux: Engel, Nora, Ghergu, Cristian, Matin, Mohammad Abdul, Kibria, Mohammad Golam, Thriemer, Kamala, Price, Ric N., Ding, Xavier C., Howes, Rosalind E., Ley, Benedikt, Incardona, Sandra, Alam, Mohammad Shafiul
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8114691/
https://ncbi.nlm.nih.gov/pubmed/33980257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-021-03743-w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires